Page last updated: 2024-10-22

pimagedine and Hypertension

pimagedine has been researched along with Hypertension in 29 studies

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research Excerpts

ExcerptRelevanceReference
"The involvement of nitric oxide (NO), prostaglandins, and calcium-dependent potassium channel (K(Ca)) activators on the negative modulation of phenylephrine-induced contractions was evaluated on the isolated aorta and caudal (CAU) artery obtained from rats treated with ouabain for 5 wk to induce hypertension."7.71Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. ( Alonso, MJ; Barker, LA; Briones, AM; Miguel, M; Rossoni, LV; Salaices, M; Vassallo, DV, 2002)
" Obesity was induced by the administration of 4 mg/g body weight of monosodium glutamate (MSG) or equimolar saline (CTR) in newborn rats."3.85iNOS inhibition improves autonomic dysfunction and oxidative status in hypertensive obese rats. ( Cecchini, R; da Cunha, NV; Lopes, FN; Martins-Pinge, MC; Panis, C; Pinge-Filho, P, 2017)
"The expression of HO-1 and iNOS in aorta increased with the SBP elevation during the development of SHR and was attenuated when the hypertension was lowered with the vasodilator hydralazine."3.72The expression of heme oxygenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats. ( Chen, JJ; Cheng, PY; Yen, MH, 2004)
"The involvement of nitric oxide (NO), prostaglandins, and calcium-dependent potassium channel (K(Ca)) activators on the negative modulation of phenylephrine-induced contractions was evaluated on the isolated aorta and caudal (CAU) artery obtained from rats treated with ouabain for 5 wk to induce hypertension."3.71Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. ( Alonso, MJ; Barker, LA; Briones, AM; Miguel, M; Rossoni, LV; Salaices, M; Vassallo, DV, 2002)
"Reduced vascular histamine content is postulated to contribute to increased peripheral vascular resistance in experimental hypertension in rats."3.67Studies on uptake and catabolism of vascular histamine in spontaneously hypertensive rats. ( Holcslaw, TL; Nichols, G; Wilson, C, 1985)
" Chronic administration of AG did not modify significantly any parameter in cirrhotic and control animals."1.31[Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites]. ( Atucha, NM; Eleno, N; Fortepiani, LA; García-Estañ, J; López-Novoa, JM; Martínez-Salgado, C; Ortiz, MC, 2001)
"Arterial hypertension has been identified as a major secondary risk factor for diabetic retinopathy."1.29Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. ( Brownlee, M; Edelstein, D; Federlin, K; Hammes, HP; Martin, S; Saleck, M, 1994)

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.45)18.7374
1990's6 (20.69)18.2507
2000's16 (55.17)29.6817
2010's5 (17.24)24.3611
2020's1 (3.45)2.80

Authors

AuthorsStudies
Zicha, J2
Řezáčová, L1
Vaněčková, I1
da Cunha, NV1
Lopes, FN1
Panis, C1
Cecchini, R1
Pinge-Filho, P1
Martins-Pinge, MC1
Kimura, Y1
Hirooka, Y1
Kishi, T1
Ito, K1
Sagara, Y1
Sunagawa, K1
Carnevale, D1
Mascio, G1
D'Andrea, I1
Fardella, V1
Bell, RD1
Branchi, I1
Pallante, F1
Zlokovic, B1
Yan, SS1
Lembo, G1
Mukohda, M1
Okada, M1
Hara, Y1
Yamawaki, H1
Huang, CF1
Hsu, CN1
Chien, SJ1
Lin, YJ1
Huang, LT1
Tain, YL1
Sharma, B1
Singh, N1
Rossoni, LV1
Salaices, M1
Miguel, M1
Briones, AM1
Barker, LA1
Vassallo, DV1
Alonso, MJ1
Tian, N1
Gannon, AW1
Khalil, RA1
Manning, RD2
Kobayashi, N1
Horinaka, S1
Mita, S1
Yoshida, K1
Honda, T1
Kobayashi, T1
Hara, K1
Nishikimi, T1
Matsuoka, H1
Pechánová, O1
Dobesová, Z1
Cejka, J1
Kunes, J1
Cheng, PY1
Chen, JJ1
Yen, MH3
Sun, Y1
Iemitsu, M1
Shimojo, N2
Miyauchi, T1
Amamiya, M1
Sumi, D1
Hayashi, T1
Sun, G1
Kumagai, Y1
Neves, SR1
Machado, CR1
Pinto, AM1
Borges, AH1
Cunha, FQ1
Camargos, ER1
McEniery, CM1
Chan, V1
Hoey, A1
Brown, L1
Wang, X1
Chang, T1
Jiang, B1
Desai, K1
Wu, L1
Castellino, P1
Tuttle, KR1
DeFronzo, RA1
Hammes, HP1
Brownlee, M2
Edelstein, D2
Saleck, M1
Martin, S1
Federlin, K1
Wolffenbuttel, BH1
van Haeften, TW1
Tsukahara, H1
Imura, T1
Tsuchida, S1
Nunose, M1
Hori, C1
Hiraoka, M1
Gejyo, F1
Sudo, M1
Liu, YC1
Hong, HJ2
Sheu, JR1
Wu, CC1
Arai, T1
Morimoto, K1
Oka, M1
Hikita, T1
Arai, K1
Umezawa, K1
Nagase, M1
Yamamoto, T1
Loh, SH1
Tan, DY1
Meng, S1
Cason, GW1
Zhu, Y1
Bian, Z1
Lu, P1
Karas, RH1
Bao, L1
Cox, D1
Hodgin, J1
Shaul, PW1
Thoren, P1
Smithies, O1
Gustafsson, JA1
Mendelsohn, ME1
Ortiz, MC1
Fortepiani, LA1
Martínez-Salgado, C1
Eleno, N1
Atucha, NM1
López-Novoa, JM1
García-Estañ, J1
Holcslaw, TL1
Nichols, G1
Wilson, C1

Reviews

1 review available for pimagedine and Hypertension

ArticleYear
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Drugs, 1995, Volume: 50, Issue:2

    Topics: Acarbose; Aldehyde Reductase; Biguanides; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hy

1995

Other Studies

28 other studies available for pimagedine and Hypertension

ArticleYear
Nitric oxide and salt resistance in Dahl rats: no role of inducible NO synthase.
    Physiological research, 2023, 03-08, Volume: 72, Issue:1

    Topics: Animals; Blood Pressure; Hypertension; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Ty

2023
iNOS inhibition improves autonomic dysfunction and oxidative status in hypertensive obese rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:1

    Topics: Animals; Arterial Pressure; Autonomic Nervous System; Dinoprostone; Enzyme Inhibitors; Guanidines; H

2017
Role of inducible nitric oxide synthase in rostral ventrolateral medulla in blood pressure regulation in spontaneously hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2009, Volume: 31, Issue:3

    Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Guanidines; Heart

2009
Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:1

    Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Alzheimer Disease; Amyloid beta-Peptides; An

2012
Methylglyoxal accumulation in arterial walls causes vascular contractile dysfunction in spontaneously hypertensive rats.
    Journal of pharmacological sciences, 2012, Volume: 120, Issue:1

    Topics: Acetylcholine; Angiotensin II; Animals; Endothelium, Vascular; Glycation End Products, Advanced; Gua

2012
Aminoguanidine attenuates hypertension, whereas 7-nitroindazole exacerbates kidney damage in spontaneously hypertensive rats: the role of nitric oxide.
    European journal of pharmacology, 2013, Jan-15, Volume: 699, Issue:1-3

    Topics: Amidohydrolases; Animals; Arginine; Blood Pressure; Citrulline; Guanidines; Hypertension; Indazoles;

2013
Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:4

    Topics: Acetophenones; Animals; Brain Chemistry; Convalescence; Dementia, Vascular; Guanidines; Hypertension

2013
Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:5

    Topics: Animals; Biological Factors; Blood Pressure; Cardiotonic Agents; Cyclooxygenase Inhibitors; Endothel

2002
Mechanisms of salt-sensitive hypertension: role of renal medullary inducible nitric oxide synthase.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2003, Volume: 284, Issue:2

    Topics: Animals; Aorta; Blood Pressure; Enzyme Induction; Glomerular Filtration Rate; Guanidines; Heart Rate

2003
Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats.
    Journal of hypertension, 2002, Volume: 20, Issue:12

    Topics: Animals; Blood Pressure; Enzyme Inhibitors; Gene Expression; Guanidines; Heart; Heart Failure; Hyper

2002
Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase.
    Journal of hypertension, 2004, Volume: 22, Issue:1

    Topics: Animals; Aorta; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inh

2004
The expression of heme oxygenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats.
    American journal of hypertension, 2004, Volume: 17, Issue:12 Pt 1

    Topics: Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Blotting, Western; Disease Mode

2004
2,4,6-Trinitrotoluene inhibits endothelial nitric oxide synthase activity and elevates blood pressure in rats.
    Archives of toxicology, 2005, Volume: 79, Issue:12

    Topics: Animals; Blood Pressure; Cell Membrane; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Guani

2005
Macrophage populations and cardiac sympathetic denervation during L-NAME-induced hypertension in rats.
    Histology and histopathology, 2006, Volume: 21, Issue:8

    Topics: Animals; Drug Therapy, Combination; Enzyme Inhibitors; Guanidines; Heart; Hemodynamics; Hypertension

2006
Novel therapeutic strategies for reducing arterial stiffness.
    British journal of pharmacology, 2006, Volume: 148, Issue:7

    Topics: Arteries; Cardiovascular Agents; Cardiovascular Diseases; Glycation End Products, Advanced; Guanidin

2006
Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
    British journal of pharmacology, 2006, Volume: 148, Issue:7

    Topics: Action Potentials; Animals; Aorta, Thoracic; Cardiovascular Diseases; Collagen; Cross-Linking Reagen

2006
Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal.
    American journal of hypertension, 2007, Volume: 20, Issue:6

    Topics: Animals; Aorta; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Free Radicals; Glutathione

2007
Diabetic nephropathy.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals;

1994
Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.
    Diabetologia, 1994, Volume: 37, Issue:1

    Topics: Aneurysm; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopat

1994
Renal functional measurements in young rats with chronic inhibition of nitric oxide synthase.
    Acta paediatrica Japonica : Overseas edition, 1996, Volume: 38, Issue:6

    Topics: Animals; Cholesterol; Creatinine; Enzyme Inhibitors; Guanidines; Hypertension; Kidney; Male; NG-Nitr

1996
Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats.
    Life sciences, 1997, Volume: 60, Issue:15

    Topics: Animals; Aorta, Thoracic; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherich

1997
Aminoguanidine induces haematuria of non-glomerular origin in spontaneously hypertensive rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:6

    Topics: Albuminuria; Animals; Arterioles; Blood Pressure; Creatinine; Glomerulonephritis; Guanidines; Hematu

2000
Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase.
    British journal of pharmacology, 2000, Volume: 131, Issue:3

    Topics: Animals; Aorta; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Hypertension;

2000
Mechanisms of salt-sensitive hypertension: role of inducible nitric oxide synthase.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2000, Volume: 279, Issue:6

    Topics: Animals; Blood Pressure; Diuresis; Glomerular Filtration Rate; Guanidines; Hemodynamics; Hypertensio

2000
Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.
    Science (New York, N.Y.), 2002, Jan-18, Volume: 295, Issue:5554

    Topics: Adrenergic alpha-Agonists; Animals; Aorta; Blood Pressure; Cells, Cultured; Estradiol; Estrogen Anta

2002
[Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6

    Topics: Animals; Ascites; Blood Pressure; Carbon Tetrachloride; Diuresis; Glomerular Filtration Rate; Guanid

2001
Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats.
    Diabetologia, 1992, Volume: 35, Issue:1

    Topics: Albuminuria; Analysis of Variance; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies;

1992
Studies on uptake and catabolism of vascular histamine in spontaneously hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 233, Issue:2

    Topics: Animals; Blood Vessels; Guanidines; Histamine; Hypertension; Imidazoles; In Vitro Techniques; Male;

1985